Skip to main content

Advertisement

Log in

Bioavailability of boswellic acids: in vitro/in vivo correlation

  • Molecular-Biological Problems of Drug Design and Mechanism of Drug Action
  • Published:
Pharmaceutical Chemistry Journal Aims and scope

Abstract

Extract of Boswellia sacra (incense tree), the main active components of which are boswellic acids, is used for the treatment of rheumatoid arthritis and gout. Boswellic acids suppress leukotriene biosynthesis in neutrophilic granulocytes by non-redox, noncompetitive inhibition of 5-lipoxygenase. Representing pentacyclic triterpenoids, boswellic acids are characterized by poor solubility in water and are highly lipophilic (1og P = 7–10.3). Bioavailability of the B. sacra (BS) extract has been studied using a new method developed for estimating and predicting the possible absorption of medicinal substances in vivo, which is based on the establishment of a correlation between the data obtained in vivo and in vitro. The validity and applicability of the proposed method is demonstrated. Release of four individual boswellic acids from BS extract has been studied in vitro using a nonconventional two-phase system simulating conditions in the gastrointestinal tract. Based on these data, the dissolution rate constants of boswellic acids have been calculated. In addition, the parameters of pharmacokinetics of ketoacids in vivo have been determined and a correlation between these parameters and the rate of release in vitro has been studied. It is established that there is a strong correlation between the results obtained in vivo and the dissolution of boswellic acids in the model two-phase medium in vitro, which makes possible prediction of the pharmacokinetic profiles of individual acids upon per os administration of BS extract.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. H. Safayhi, S. E. Boden, S. Schweizer, and H. P. T. Ammon, Planta Med., 66, 110–113 (2000).

    Article  PubMed  CAS  Google Scholar 

  2. H. P. Ammon, Wien Med. Wochenschr., 152(15, 16), 373–378 (2002).

    Article  PubMed  CAS  Google Scholar 

  3. D. A. Wyatt, Bull. Techn. Gattefosse, 92, 31–39 (1999).

    CAS  Google Scholar 

  4. G. L. Amidon, H. Lennernäs, V. P. Shah, and J. R. Crison, Pharm. Res., 12, 413–420 (1995).

    Article  PubMed  CAS  Google Scholar 

  5. N. N. Karkishchenko, V. V. Khoron’ko, S. A. Sergeeva, et al., Pharmacokinetics [in Russian], Fenix, Rostov-on-Don (2001).

    Google Scholar 

  6. J. Emami, J. Pharm. Pharm. Sci., 9(1), 82–100 (2006).

    Google Scholar 

  7. V. R. S. Uppoor, J. Control. Rel., 72(1–3), 127–132 (2001).

    Article  CAS  Google Scholar 

  8. V. K. Piotrovskii, Farmakol. Toksikol., 49(5), 118–127 (1986).

    PubMed  CAS  Google Scholar 

  9. V. Pillay and R. Fassihi, J. Pharm. Sci., 88, 843–851 (1999).

    Article  PubMed  CAS  Google Scholar 

  10. M. V. Karlina, A. Yu. Eshenko, G. I. D’yachuk, and O. N. Pozharitskaya, Proceedings of the 9th Int. Congr. PHYTOPHARM-2005, St. Petersburg (2005), pp. 665–669.

Download references

Author information

Authors and Affiliations

Authors

Additional information

__________

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 41, No. 11, pp. 3–6, November, 2007.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Karlina, M.V., Pozharitskaya, O.N., Kosman, V.M. et al. Bioavailability of boswellic acids: in vitro/in vivo correlation. Pharm Chem J 41, 569–572 (2007). https://doi.org/10.1007/s11094-008-0017-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-008-0017-x

Keywords

Navigation